EASI-75 interpretation from a patient perspective - a phase 2b post-hoc analysis of dupilumab in adults with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Poulin, Y. [1 ,2 ]
Tyring, S. [3 ,4 ]
Kimura, T. [5 ]
Andria, M. [5 ]
Ghorayeb, E. [6 ]
Eckert, L. [7 ]
Chao, J. [5 ]
机构：
[1] Ctr Rech Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Univ Texas Hlth Sci Ctr Houston, Ctr Clin Studies, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA
[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[6] Sanofi, Cambridge, MA USA
[7] Sanofi, Chilly Mazarin, France
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [21] TEMPORAL RESPONSE PATTERNS OF ABROCITINIB AND DUPILUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF THE JADE DARE TRIAL
    Trzeciak, Magdalena
    Chovatiya, Raj
    Geng, Bob
    Biswas, Pinaki
    Guler, Erman
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 30 - 31
  • [22] Dupilumab improves symptoms of anxiety and depression in adults with moderate-to-severe atopic dermatitis: A post hoc analysis of three phase 3 trials (LIBERTY AD SOLO 1 & 2 And CHRONOS)
    Silverberg, J.
    Thyssen, J. P.
    Armstrong, A.
    Gadkari, A.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Rossi, A. B.
    Eckert, L.
    [J]. ALLERGY, 2019, 74 : 182 - 183
  • [23] SCORAD severity band threshold analysis from dupilumab clinical trials in adults with moderate-to-severe atopic dermatitis
    Wollenberg, Andreas
    Simpson, Eric L.
    Leshem, Yael A.
    Taieb, Alain
    Katoh, Norito
    Chao, Jingdong
    Rossi, Ana B.
    Praestgaard, Amy
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [24] Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial
    Blauvelt, A.
    Teixeira, H. D.
    Simpson, E. L.
    Costanzo, A.
    De Bruin-Weller, M.
    Barbarot, S.
    Prajapati, V. H.
    Lio, P.
    Hu, X.
    Wu, T.
    Liu, J.
    Ladizinski, B.
    Chu, A. D.
    Eyerich, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E123
  • [25] Tralokinumab provides progressive and sustained efficacy in adolescents with moderate-to-severe atopic dermatitis: a post-hoc analysis of the ECZTRA 6 trial
    Simpson, Eric L.
    Wollenberg, Andreas
    Kurbasic, Azra
    Tindberg, Ann-Marie
    Soldbro, Lise
    Paller, Amy S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [26] Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 & 2 and ADOL)
    Silverberg, Jonathan
    Soong, Weily
    Lockshin, Benjamin
    Gadkari, Abhijit
    Chen, Zhen
    Bansal, Ashish
    Eckert, Laurent
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
  • [27] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
  • [28] ABSOLUTE EASI TARGET IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF DATA FROM THE MEASURE UP 1 AND 2 STUDIES
    Prajapatil, Vimal
    Simpson, Eric L.
    Thyssen, Jacob P.
    Chovatiya, Raj
    Lane, Michael
    Teixeira, Henrique
    Calimlim, Brian
    Silverberg, Jonathan I.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 33 - 33
  • [29] Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
    Shi, Vivian Y.
    Bhutani, Tina
    Fonacier, Luz
    Deleuran, Mette
    Shumack, Stephen
    Valdez, Hernan
    Zhang, Fan
    Chan, Gary L.
    Cameron, Michael C.
    Yin, Natalie C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 351 - 358
  • [30] Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
    Sher, Lawrence
    Soong, Weily
    Mina-Osorio, Paola
    Prescilla, Randy
    Chen, Zhen
    Bansal, Ashish
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
12345